ASSET ACQUISITION (Additional Information) (Details) |
12 Months Ended |
|---|---|
|
Dec. 31, 2025
USD ($)
shares
| |
| Asset Acquisition [Line Items] | |
| Common shares issued and reserved | 401,126 |
| Consideration transferred | $ | $ 8,500,000 |
| promissory note | $ | 577,000 |
| Salarius Pharmaceuticals [Member] | |
| Asset Acquisition [Line Items] | |
| Aggregated fair value | $ | $ 4,302,000 |
| Series A Stock | |
| Asset Acquisition [Line Items] | |
| Shares issued of Series A Non-Voting Convertible Preferred Stock | 877.709 |
| Convertible Preferred Stock Shares Reserved | 796.306 |
| Series B Stock | |
| Asset Acquisition [Line Items] | |
| Shares issued of Series A Non-Voting Convertible Preferred Stock | 796.306 |
| Nonvoting Common Stock [Member] | |
| Asset Acquisition [Line Items] | |
| Shares issued of Series A Non-Voting Convertible Preferred Stock | 877.709 |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Fair value at acquisition date of equity interest in acquiree held by acquirer immediately before acquisition date in business combination achieved in stages. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Number of shares issued for each share of convertible preferred stock that is converted. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate number of nonredeemable convertible preferred shares reserved for future issuance. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of principal of debt issued. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Number of common shares issuable upon conversion of preferred stock. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|